Director, Global Commercial, Cell Therapy, Multiple Myeloma

The Global Commercial Multiple Myeloma Director will set strategic vision and go‑to‑market plans for the MM CAR‑T business, including launch readiness for arlo‑cel and other lifecycle opportunities, while also shaping commercial strategy for new multiple myeloma assets in late‑stage development. Reporting to the VP of Global Commercial, Cell Therapy, Hematology, the role collaborates across matrixed teams to ensure globally aligned, locally relevant execution.